Legend Biotech (LEGN): Analyst Consensus Predicts a 147.72% Potential Upside in Biotech Stock

Legend Biotech Corporation (NASDAQ: LEGN) is emerging as a compelling player in the biotechnology sector, particularly for investors who are keen on the dynamic field of cell therapy. With a market capitalization of $3.87 billion, Legend Biotech is positioned at the forefront of developing and commercializing innovative treatments for cancer, with its lead product candidate, […]